Skip to main content
Caplight Logo









Ziel Biosciences

Ziel Biosciences

Private
Porto AlegreHealthcare & Life Scienceshttps://bumi303-seo.com/

Last Round

Early Funding

Sep 27, 2022

Total Funding Raised

$33.15M

Company Overview

Ziel Biosciences is a biotechnology company that develops oncology technology-based products for cancer treatment and women's health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Application

Keywords

cervical cancer screeningbiotechnologydiagnostic technologyself-sampling kitfemtechoncology diagnosticstumor chemosensitivityin vitro diagnosticsIVDprecision medicinemedical devicepoint of care diagnosticsPOC diagnosticsdrug discoveryhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ziel Biosciences Comparables

Compare Ziel Biosciences with similar companies based on industry and business-model similarity.

Ziel Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Teal Health
77%
Gynius Plus AB
75%
Eve Medical
70%

Ziel Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 27, 2022
Series ASep 26, 2019
GrantJun 3, 2013

Key People

Founding team and executive leadership

Caroline Brunetto de Farias

Founder - CEO

Founding Team

Daniela Cornelio

CEO

Executive Team

Camila Alves

Chief Technology Officer

Executive Team

Ziel Biosciences Investors

Notable investors and investment history

Ziel Biosciences investors
InvestorRounds
Mass General Brigham InnovationSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 27, 2022

    $7.5M raised in early funding.

  • Jun 3, 2013

    $50K grant received from Commonwealth Research Commercialization Fund.

Ziel Biosciences Filings

Explore SEC and related filing metadata, where available.

Ziel Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ziel Biosciences's valuation, stock price, and market status.

Is Ziel Biosciences a public or private company?

Ziel Biosciences is a private company.

What is the current stock price of Ziel Biosciences?

Ziel Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Ziel Biosciences worth (valuation)?

Valuation information for Ziel Biosciences is not publicly available.

Can I buy Ziel Biosciences stock?

Ziel Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ziel Biosciences's last funding round?

Ziel Biosciences's most recent funding round was Early Funding on September 27, 2022.

Who are the main investors in Ziel Biosciences?

Key investors in Ziel Biosciences include Mass General Brigham Innovation.

Will Ziel Biosciences IPO soon?

No public IPO plans have been announced for Ziel Biosciences.

How can I track Ziel Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ziel Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPorto Alegre
Employee Range7
Year Founded2011
Last FundingSep 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?